112 related articles for article (PubMed ID: 11007058)
1. Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I.
Shamseddine A; Taher A; Jaafar H; Haidar JH; Nasr R; Arzoumanian V; Salem Z; Bazarbachi A
Eur J Haematol; 2000 Sep; 65(3):207-9. PubMed ID: 11007058
[TBL] [Abstract][Full Text] [Related]
2. Effects of four species of interferon-alpha on cultured erythroid progenitors from congenital dyserythropoietic anaemia type I.
Menike D; Wickramasinghe SN
Br J Haematol; 1998 Dec; 103(3):825-30. PubMed ID: 9858239
[TBL] [Abstract][Full Text] [Related]
3. Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.
Yarali N; Fişgin T; Duru F; Atilla P; Müftüoğlu SF; Kaymaz SF
Pediatr Hematol Oncol; 2005 Jun; 22(4):265-70. PubMed ID: 16020112
[TBL] [Abstract][Full Text] [Related]
4. Interferon therapy in congenital dyserythropoietic anemia type I/II.
Marwaha RK; Bansal D; Trehan A; Garewal G
Pediatr Hematol Oncol; 2005 Mar; 22(2):133-8. PubMed ID: 15804998
[TBL] [Abstract][Full Text] [Related]
5. [Erythroid colonies derived from BFU-E from the bone marrow in a patient with type I congenital dyserythropoietic anemia].
Florensa L; Woessner S; Almarcha J; Pardo Peret P; Lafuente R; Vilá RM
Sangre (Barc); 1990 Jun; 35(3):219-21. PubMed ID: 2396168
[TBL] [Abstract][Full Text] [Related]
6. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
[TBL] [Abstract][Full Text] [Related]
7. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Ramos J; Delfour C; Henry L; Guiraud I; Carillo S; Wagner A; Bureau JP; Blanc P
Eur J Haematol; 2004 Nov; 73(5):380-3. PubMed ID: 15458519
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural characterization of the erythroid cells in a novel case of congenital anemia.
Antonelou MH; Papassideri IS; Karababa FJ; Loutradi A; Margaritis LH
Blood Cells Mol Dis; 2003; 30(1):30-42. PubMed ID: 12667985
[TBL] [Abstract][Full Text] [Related]
9. Congenital dyserythropoietic anemia type II: morphological characterization of the erythroid colonies (BFU-E) from the bone marrow and peripheral blood of two patients.
Florensa L; Woessner S; Besses C; Solé F; Sans-Sabrafen J
Ann Hematol; 1994 Aug; 69(2):57-9. PubMed ID: 8080879
[TBL] [Abstract][Full Text] [Related]
10. Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b.
Roda L; Pasche J; Fournier A; Terorotua V; Wickramasinghe SN; Tamary H; Schischmanoff PO; Tchernia G; Delaunay J
J Pediatr Hematol Oncol; 2002; 24(6):503-6. PubMed ID: 12218603
[TBL] [Abstract][Full Text] [Related]
11. Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II.
Barosi G; Cazzola M; Stefanelli M; Ascari E
Br J Haematol; 1979 Oct; 43(2):243-50. PubMed ID: 508633
[TBL] [Abstract][Full Text] [Related]
12. RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.
De Rosa G; Andolfo I; Marra R; Manna F; Rosato BE; Iolascon A; Russo R
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759740
[TBL] [Abstract][Full Text] [Related]
13. Reduced interferon-alpha production by Epstein-Barr virus transformed B-lymphoblastoid cell lines and lectin-stimulated lymphocytes in congenital dyserythropoietic anaemia type I.
Wickramasinghe SN; Hasan R; Smythe J
Br J Haematol; 1997 Aug; 98(2):295-8. PubMed ID: 9266923
[TBL] [Abstract][Full Text] [Related]
14. Congenital dyserythropoietic anaemia type II (CDA-II): chromosomal banding studies and adherent cell effects on erythroid colony (CFU-E) and burst (BFU-E) formation.
Roodman GD; Clare CN; Mills G
Br J Haematol; 1982 Mar; 50(3):499-507. PubMed ID: 7066202
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.
Roy NBA; Babbs C
Br J Haematol; 2019 May; 185(3):436-449. PubMed ID: 30836435
[TBL] [Abstract][Full Text] [Related]
16. Congenital dyserythropoietic anaemia type II-like dysplastic anaemia preceding the development of non-Hodgkin lymphoma--a case report.
Leong CF; Zainina S; Cheong SK
Malays J Pathol; 2005 Jun; 27(1):39-43. PubMed ID: 16676692
[TBL] [Abstract][Full Text] [Related]
17. Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy.
Parez N; Dommergues M; Zupan V; Chambost H; Fieschi JB; Delaunay J; Miélot F; Cramer EM; Dommergues JP; Wickramasinghe SN; Tchernia G
Br J Haematol; 2000 Aug; 110(2):420-3. PubMed ID: 10971401
[TBL] [Abstract][Full Text] [Related]
18. Congenital dyserythropoietic anemia type III.
Sandström H; Wahlin A
Haematologica; 2000 Jul; 85(7):753-7. PubMed ID: 10897128
[TBL] [Abstract][Full Text] [Related]
19. Congenital dyserythropoietic anaemia type I: absence of clonal expression in the nuclear abnormalities of cultured erythroblasts.
Vainchenker W; Guichard J; Bouguet J; Breton-Gorius J
Br J Haematol; 1980 Sep; 46(1):33-7. PubMed ID: 7426450
[TBL] [Abstract][Full Text] [Related]
20. Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.
Rathe M; Møller MB; Greisen PW; Fisker N
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
